Prostate cancer-related nucleic acids
View Patent ↗Described herein are novel polynucleotides associated with prostate cancer. The polynucleotides are miRNAs, miRNA precursors, and associated nucleic acids. Methods and compositions are described that can be used for diagnosis, prognosis, and treatment of prostate cancer. Also described herein are methods that can be used to identify modulators of the disease-associated polynucleotides. Also described herein are methods and compositions for linear amplification and labeling of a targeted nucleic acid. The amplified targeted molecules may be used in hybridization techniques like Luminex and Microarray analysis.
1. An isolated nucleic acid comprising a sequence selected from the group consisting of:
(a) SEQ ID NO: 14;
(b) complement of (a); and
(c) sequence at least 80% identical to (a) or (b), wherein the nucleic acid is from 18 to 100 nucleotides in length.
2. The nucleic acid of claim 1 wherein the nucleic acid comprises a modified base.
3. A probe comprising a heterologous sequence, wherein the heterologous sequence consists of the sequence of the nucleic acid of claim 1 .
4. The probe of claim 3 , wherein the nucleic acid is a miRNA.
5. A biochip comprising the probe of claim 3 .
6. A vector comprising a heterologous sequence, wherein the heterolgous sequence consists of the sequence of the nucleic acid of claim of 1.